jtx-2134
·Code: JTX-2134
jtx-2134: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Jounce Therapeutics, Inc. (JNCE) | Preclinical |
Get deeper analysis on jtx-2134
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis